Files and links (1)
CC BY V4.0, Open Access
Journal article
Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
JAMA dermatology (Chicago, Ill.)
2025
PMID: 41222950
Abstract
Importance Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) survivors experience substantial long-term sequelae. Research on physical symptoms experienced during acute hospitalization is well documented, but limited studies have been completed on the long-term biopsychosocial effects of SJS/TEN, particularly from the patient’s perspective.
Objective To increase the understanding of the long-term complications of SJS/TEN.
Design, Setting, and Participants This qualitative investigation was completed from within a community-based study, the SJS Survivors Study, using a semistructured, in-depth interview guide to query participants about their SJS/TEN experience postdischarge from the hospital. Interviews took place by phone from July 2021 through August 2023. This study included adults who experienced SJS/TEN within the United States.
Main Outcome and Measures A biopsychosocial theory-based framework and hierarchical coding system were utilized to understand the long-term life impacts of survivors of SJS/TEN.
Results The 29 participants, aged 26 to 76 years, were 66% female and 69% White and had experienced SJS/TEN from a wide range of drugs. Patients experienced support while in the hospital, but once discharged, felt isolated and without support to understand the potential sustained impacts of SJS/TEN in their lives and the lives of their family members. Patients experienced ongoing biological symptoms, such as skin issues, debilitating visual impairment, blindness, and lack of functional autonomy. Psychological impacts included symptoms of anxiety, obsessive thinking, flashbacks, and depression. Socially, some survivors expressed a sense of abandonment and described negative impacts on their careers. Survivors also expressed frustration and isolation with having to navigate posthospital care alone. There was a lack of preemptive discharge education and SJS/TEN-specific planning. Lack of physician knowledge about SJS/TEN was particularly noted and survivors turned to the internet for guidance instead of receiving direction from their physicians. Medical distrust among survivors was frequently noted.
Conclusions and Relevance The findings highlight the need for postdischarge care coordination among patients and their primary physicians, including mental health support. This care coordination should be arranged prior to discharge to ensure the availability of adequate support and optimal health outcomes. It is essential that clinicians and researchers prioritize the understanding of long-term sequelae of SJS/TEN and improve current discharge education and protocols for patients and their families.
Details
- Title
- Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- Authors/Creators
- Michelle D Martin-Pozo - Vanderbilt University Medical CenterElizabeth A Williams - Vanderbilt University Medical CenterKemberlee R Bonnet - Vanderbilt UniversityBenjamin H Kaffenberger - The Ohio State University Wexner Medical CenterDavid G Schlundt - Vanderbilt UniversityElizabeth J Phillips - Institute for Immunology and Infectious Diseases, Murdoch University, Perth, AustraliaSJS Survivor Study
- Publication Details
- JAMA dermatology (Chicago, Ill.)
- Publisher
- JAMA Network
- Number of pages
- 7
- Identifiers
- 991005830346007891
- Copyright
- © 2025 Martin-Pozo MD et al.
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Metrics
7 File views/ downloads
7 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.265 Dermatology - Skin Allergies
- 1.265.1140 Drug Hypersensitivity
- Web Of Science research areas
- Dermatology
- ESI research areas
- Clinical Medicine